Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2015

Open Access 01-12-2015 | Research

Translation and validation of the Chinese version of the Current Opioid Misuse Measure (COMM) for patients with chronic pain in Mainland China

Authors: Yang Zhao, Yuli Li, Xuekun Zhang, Fenglan Lou

Published in: Health and Quality of Life Outcomes | Issue 1/2015

Login to get access

Abstract

Background

Management of prescription opioids misuse and abuse problems among chronic pain patients has been increasingly important worldwide and little literature concerning prescription opioids can be found in mainland China so far.

Methods

The Current Opioid Misuse Measure (COMM) was translated into Chinese following Brislin’s model of cross-culture translation and was completed by a convenience sample of 180 patients with chronic pain recruited from two major hospitals in Jinan, Shandong province. Data were analyzed using internal consistency, test-retest reliability, exploratory factor analysis and confirmatory factor analysis.

Results

The internal consistency coefficient for the total score of the COMM was 0.85 and item-total correlations of all items were above 0.20. Besides, the test-retest reliability was satisfactory with an ICC of 0.91 (95 % CI = 0.65-0.98). Four principal components were extracted, accounting for 65.30 % of the variance, and the factor loadings of all 17 items were above 0.40.

Conclusions

The Chinese version of COMM showed satisfactory reliability and validity, and could be used as a screening tool to evaluate and monitor current aberrant drug-related behavior among Chinese patients with chronic pain.
Literature
1.
Roxburgh A, Bruno R, Larance B, Burns L. Prescription of opioid analgesics and related harms in Australia. Med J Aust. 2011;195(5):280–4.CrossRefPubMed
2.
Manchikanti L, Helm 2nd S, Fellows B, Janata JW, Pampati V, Grider JS, et al. Opioid epidemic in the United States. Pain Physician. 2012;15(3 Suppl):ES9–38.PubMed
3.
Fischer B, Argento E. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician. 2012;15(3 Suppl):ES191–203.PubMed
4.
Dhalla IA, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ. 2009;181(12):891–6.PubMedCentralCrossRefPubMed
5.
Smith SM, Dart RC, Katz NP, Paillard F, Adams EH, Comer SD, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013;154(11):2287–96.CrossRefPubMed
6.
Hartrick CT, Gatchel RJ, Conroy S. Identification and management of pain medication abuse and misuse: current state and future directions. Expert Rev Neurother. 2012;12(5):601–10.CrossRefPubMed
7.
Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004;112(1–2):65–75.CrossRefPubMed
8.
Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage. 1998;16(6):355–63.CrossRefPubMed
9.
Passik SD, Kirsh KL, Whitcomb L, Portenoy RK, Katz NP, Kleinman L, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004;26(4):552–61.CrossRefPubMed
10.
Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6):432–42.CrossRefPubMed
11.
12.
Butler SF, Budman SH, Fernandez KC, Houle B, Benoit C, Katz N, et al. Development and Validation of the Current Opioid Misuse Measure. Pain. 2007;130(1–2):144–56.PubMedCentralCrossRefPubMed
13.
Butler SF, Budman SH, Fanciullo GJ, et al. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clin J Pain. 2010;26(9):770–6.PubMedCentralCrossRefPubMed
14.
Meltzer EC, Rybin D, Saitz R, Jamison RN. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM). Pain. 2011;152(2):397–402.PubMedCentralCrossRefPubMed
15.
Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–30.PubMedCentralCrossRefPubMed
16.
Finkelman MD, Kulich RJ, Zoukhri D, Smits N, Butler SF. Shortening the Current Opioid Misuse Measure via computer-based testing: a retrospective proof-of-concept study. BMC Med Res Methodol. 2013;13:126.PubMedCentralCrossRefPubMed
17.
Brislin RW. The wording and translation of research instruments. In: Field methods in cross-cultural research. Newbury Park,CA: Sage; 1986. p. 185–216.
18.
Valmi DS, Wilaiporn R. Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline. J Eval Clin Pract. 2011;17(2):268–74.CrossRef
19.
Polit DF, Beck CT. The content validity index: are you sure you know what’s being reported? Res Nurs Health. 2006;29:489–97.CrossRefPubMed
20.
DeVellis RF. Scale development: theory and applications. 3rd ed. Thousand Oaks: Sage; 2003. p. 27–47.
21.
Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychol Rep. 1966;19:3–11.CrossRefPubMed
22.
Bartlett MS. Tests of significance in factor analysis. Br J Psychol. 1950;3:77–85.
23.
Wakefield DS, Wakefield BJ, Uden-Holman T, et al. Understanding why medication administration errors may not be reported. Am J Med Qual. 1999;14(2):81–8.CrossRefPubMed
24.
Hooper D, Coughlan J, Mullen MR. Structural equation modelling: Guidelines for determining model fit. J Bus Res Meth. 2008;6:53–60.
25.
Adams LL, Gatchel RJ, Robinson RC, Polatin P, Gajraj N, Deschner M, et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage. 2004;27(5):440–59.CrossRefPubMed
Metadata
Title
Translation and validation of the Chinese version of the Current Opioid Misuse Measure (COMM) for patients with chronic pain in Mainland China
Authors
Yang Zhao
Yuli Li
Xuekun Zhang
Fenglan Lou
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2015
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-015-0329-y

Other articles of this Issue 1/2015

Health and Quality of Life Outcomes 1/2015 Go to the issue

Research

Measurement of change in health status with Rasch models

Research Article

Quantifying the importance of disease burden on perceived general health and depressive symptoms in patients within the Mayo Clinic Biobank

Research

Validity and reliability of EQ-5D-3L for breast cancer patients in Korea

Research

Multimorbidity and functional decline in community-dwelling adults: a systematic review

Research

Translation and validation of the Malay version of Shiffman-Jarvik withdrawal scale and cessation self-efficacy questionnaire: a review of psychometric properties

Research

Preoperative and early postoperative quality of life after major surgery - a prospective observational study